Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Diastika Biotekindo TbkISX:CHEK -1.46% FCF Yield % is 0.00 as of Aug. 24, 2026. The stock has 1 warning sign investors should review. Among 118 Medical Distribution companies, PT Diastika Biotekindo Tbk ranks worse than 847456.78% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for PT Diastika Biotekindo Tbk's FCF Yield % or its related term are showing as below:
ISX:CHEK's FCF Yield % is not ranked *
in the Medical Distribution industry.
Industry Median: 1.1 * Ranked among companies with meaningful FCF Yield % only.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
PT Diastika Biotekindo Tbk FCF Yield % Related Terms
PT Diastika Biotekindo Tbk FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Diastika Biotekindo Tbk FCF Yield % Chart
PT Diastika Biotekindo Tbk Annual Data
Trend
FCF Yield %
PT Diastika Biotekindo Tbk Semi-Annual Data
FCF Yield %
ISX:CHEK vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Distribution subindustry, PT Diastika Biotekindo Tbk's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Diastika Biotekindo Tbk FCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Diastika Biotekindo Tbk's FCF Yield % distribution charts can be found below:
* The bar in red indicates where PT Diastika Biotekindo Tbk's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Diastika Biotekindo Tbk (ISX:CHEK) has a FCF Yield % of 0.00 as of Aug. 24, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PT Diastika Biotekindo Tbk and its competitors. According to the industry distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 118 companies in the Medical Distribution industry.
Is PT Diastika Biotekindo Tbk's FCF Yield % too high?
PT Diastika Biotekindo Tbk's current FCF Yield % is 0.00. Based on the distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers.
How does PT Diastika Biotekindo Tbk's FCF Yield % compare to ABT and SYK?
According to the Medical Distribution industry distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 118 companies for FCF Yield %. This places PT Diastika Biotekindo Tbk in the lower half of its industry. The industry median FCF Yield % is 1.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Distribution company?
The median FCF Yield % among Medical Distribution companies is 1.10, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PT Diastika Biotekindo Tbk and its competitors. For the Medical Distribution industry, the median FCF Yield % is 1.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Diastika Biotekindo Tbk's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diastika Biotekindo Tbk stock overvalued right now?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a current FCF Yield % of 0.00. The current FCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For PT Diastika Biotekindo Tbk (ISX:CHEK), the current FCF Yield % is 0.00 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressJalan Rawagelam V, Kawasan Industri Pulogadung, Block L, No. Kav 11-13, Gedung Etana Lantai 3, Desa/Kelurahan Jatinegara, Kec. Cakung, Kota Adm. Jakarta Timur, Jakarta, IDN, 13930
PT Diastika Biotekindo Tbk is engaged in providing medical and laboratory equipment solutions in Indonesia. It is engaged in the wholesale trading of laboratory equipment, pharmaceutical products, and medical devices for human use. The company is also involved in wholesale trading of radioactive substances and ionizing radiation generators, and undertakes activities related to the testing and/or calibration of medical devices, as well as the inspection of healthcare facilities and infrastructure. Its product offerings mainly include devices like hematology analyzer, pipette, hemoglobin testing system, etc. The company's operating segments are: Diagnostics Group, which generates the maximum revenue, and Life Sciences Group. Geographically, all of its revenue is derived from Indonesia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CHEK has been successfully added to your 
